Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial. (Q55044630)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/17869635

Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial. (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/17869635

1 reference

based on heuristic

inferred from title

venous thromboembolism

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Bengt I Eriksson

1

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/17869635

Ola E Dahl

2

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/17869635

Nadia Rosencher

3

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/17869635

Andreas A Kurth

4

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/17869635

C Niek van Dijk

5

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/17869635

Simon P Frostick

6

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/17869635

Martin H Prins

7

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/17869635

Rohan Hettiarachchi

8

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/17869635

Stefan Hantel

9

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/17869635

Janet Schnee

10

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/17869635

Harry R Büller

11

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/17869635

RE-NOVATE Study Group

12

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/17869635

language of work or name

0 references

publication date

1 September 2007

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/17869635

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/17869635

370

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/17869635

9591

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/17869635

949-956

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/17869635

Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961445-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961445-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961445-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prolonged thromboprophylaxis with oral anticoagulants after total hip arthroplasty: a prospective controlled randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961445-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961445-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Temporal trends in prevention of venous thromboembolism following primary total hip or knee arthroplasty 1996-2001: findings from the Hip and Knee Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961445-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Antithrombotic therapy practices in US hospitals in an era of practice guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961445-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961445-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral anticoagulants in development: focus on thromboprophylaxis in patients undergoing orthopaedic surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961445-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Emerging anticoagulants for the treatment of venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961445-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Structure-based design of novel potent nonpeptide thrombin inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961445-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961445-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Roentgen diagnosis of venous thrombosis in the leg

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961445-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimization of ascending phlebography of the leg for screening of deep vein thrombosis in thromboprophylactic trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961445-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The challenges of new drugs benefits and risks analysis: lessons from the ximelagatran FDA Cardiovascular Advisory Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961445-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961445-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Low molecular weight heparin associated with spinal anaesthesia and gradual compression stockings in total hip replacement surgery. Arar Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961445-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961445-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction of out-of-hospital symptomatic venous thromboembolism by extended thromboprophylaxis with low-molecular-weight heparin following elective hip arthroplasty: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961445-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Deep venous thrombosis prophylaxis: better living through chemistry--in opposition

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961445-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Methodological issues in trials assessing primary prophylaxis of venous thrombo-embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961445-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Thromboembolism prevention in ischaemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961445-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(07)61445-7

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/17869635

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/17869635

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q55044630&oldid=2105022359"